Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06535503
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-05-13
Brief Title:
Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Clinical Characteristics and Outcomes Among ST-elevation Myocardial Infarction STEMI Patients With Cardiogenic Shock at Abu Dhabi City
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction STEMI complicated with cardiogenic shock CS during admission or CS development during their hospital stay for two tertiary hospitals in Abu Dhabi UAE from 2020-2024
Detailed Description:
Cardiovascular disease CVD accounts for 40 of mortality in the UAE which is higher than the global average Long-term trends incidence studies and best practice guidance on Cardiogenic Shock CS with ST-elevation Myocardial infarction STEMI in the United Arab Emirates UAE and the Gulf Cooperation Council GCC are limited
Through this retrospective study investigators aim to identify treatment modalities and trends hospitalization events and patient demographics and comorbidities which lead to participant recovery or mortality in Sheikh Khalifa Medical City SKMC and Sheikh Shakhbout Medical City SSMC tertiary hospitals for patients admitted with STEMI and CS or developed CS after hospitalization with STEMI during January 2020-January 2024200-400 participants Data will be collected from eligible patients electronic medical records EMR
Through this retrospective study investigators aim to identify treatment modalities and trends hospitalization events and patient demographics and comorbidities which lead to participant recovery or mortality in Sheikh Khalifa Medical City SKMC and Sheikh Shakhbout Medical City SSMC tertiary hospitals for patients admitted with STEMI and CS or developed CS after hospitalization with STEMI during January 2020-January 2024200-400 participants Data will be collected from eligible patients electronic medical records EMR
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None